Since statins were introduced for the treatment of high cholesterol, the wealthy have seen a decline in lipid levels double to that of the poor.

A study by researchers at the Philadelphia Veterans Affairs Medical Center, the University of Pennsylvania and the University of Chicago analyzed the social disparities in the treatment of cardiovascular disease since statins were introduced. Their research findings are published in the September issue of Journal of Health and Social Behavior.
The researchers note that high cholesterol used to be a rich man’s disease. They had easier access to high fat foods like red meat. Because wealthier Americans …read more